SEC Form 4 · accession 0001209191-15-049312
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J Williams Ph.D.
Officer — Executive Vice President
Period of report
Jun 1, 2015
Accepted (ET)
Jun 3, 2015 · 9:57 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 1, 2015 | M | 1,299 | $0.00 | A | 16,685 | D | |
| Common Stock | Jun 1, 2015 | F | 86 | $135.53 | D | 16,599 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitF2 | — | Jun 1, 2015 | M | 1,299 | D | — | — | Common Stock | 1,299 | 6,795 | D |
Explanation of responses
- F1Includes 42 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 3/31/2015.
- F2Represents restricted stock units previously granted on 06/01/2011 that have vested. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date of the date of grant (06/01/2011).